Hims & Hers Health (HIMS) stock gains after its Q3 2024 results as company plans to launch a generic version of Novo ...

The millennial-skewed telehealth platform Hims & Hers (HIMS) announced Monday that it will start offering customers a generic version of liraglutide, an older GLP-1 weight loss drug, next year. The ...

Shares jump over 5% as Hims & Hers unveils plans for the first generic GLP-1--targeting Novo's weight-loss dominance ...

Hims & Hers anticipates selling a generic version of NVO's liraglutide, threatening sales as soon as next year. Intense ...

Telehealth platform Hims & Hers will begin offering a generic version of liraglutide, a GLP-1 weight loss drug, to its customers in 2025, Quartz reported Nov. 4.

Telehealth company Hims & Hers said late Monday in an earnings update that it plans to launch a generic version of Novo ...

Hims & Hers Health reported third-quarter results that topped Street expectations Monday and said it plans to release a ...

Hims & Hers Health Inc. ($HIMS) rallied nearly 9% in pre-market trading on Tuesday, following the company’s third-quarter ...

CVS Caremark and Express Scripts, along with GoodRx and others, are accused of working together to suppress reimbursements to independent pharmacies in at least three class-action lawsuits. Also, Hims ...

Western officials are investigating whether devices planted at shipping hubs in Europe may have been a test run by Russian operatives for placing them on planes bound for the U.S. By Michael ...

Tens of thousands of U.S. citizens live in the Israeli-occupied territory, on opposing sides of an entrenched conflict, where neither Palestinians nor Israelis have much enthusiasm for Kamala ...

Three gangsters entered a West Delhi showroom in broad daylight yesterday, gave the owner an extortion note with an amount written on it, fired multiple times in the air to drive home their ...